<DOC>
	<DOC>NCT02220556</DOC>
	<brief_summary>Fifteen cohorts will be opened. Each cohort will explore one analysis method and/or tumoral type. Up to 50 patient can be included into each cohort.</brief_summary>
	<brief_title>Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology</brief_title>
	<detailed_description />
	<mesh_term>Neoplastic Cells, Circulating</mesh_term>
	<criteria>18 years old or more Performance status from 0 to 4 Patient treated followed for histologically confirmed solid tumor type of any of these localization : breast, prostate, uterus, ovary, colon, lung, head and neck, melanoma. Informed consent form signed. Patient with history of other invasive cancer within 5 years. Patient treated for any noninvasive cancer Patient individually deprived of liberty or placed under the authority of a tutor Geographical condition potentially preventing compliance with the study protocol.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>